Biologics Market, By Product, By Drug Classification, By Route of Administration, By Mode of Purchase, By Distribution Channel,By Geography .

Description

Global biologics market is estimated to be valued at USD 522.1 Mn in 2024 and is expected to reach USD 1,044.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.4% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 522.1 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	10.40%	2031 Value Projection:	US$ 1,044.2 Mn

Figure. Biologics Market Share (%), By Region 2024

Biologics refers to medicines created from living organisms that are used to prevent, treat, and cure human diseases. These include vaccines, blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Increasing prevalence of chronic diseases worldwide coupled with rising elderly population prone to various illnesses can boost demand for biologics. Rapid innovations and advancements in biotechnology have enabled development of novel biologic agents with improved safety, efficacy and specificity of action. This has expanded treatment options for several life-threatening conditions such as cancer, rheumatic disorders, and autoimmune diseases. Growing regulatory approvals and commercialization of biologics can drive the market growth.

Market Dynamics

Global biologics market growth is driven by growing prevalence of chronic diseases worldwide such as diabetes, cancer, cardiovascular diseases along with rising healthcare expenditure on biopharmaceutical R&D. Increasing demand for protein-based drugs, rapid approvals of advanced biologics and strong pipeline of novel biologic candidates can also drive the market growth. Constant technological advancements in bioprocessing and quality analytics enables development of high-yield production platforms conducive for cost-effective manufacturing of biologics at commercial scale. However, factors such as high capital investment needs for setting up bio-manufacturing facilities, stringent regulatory norms, and complexity of biological molecules poses challenges in biosimilar development. Emerging markets across developing regions such as Asia Pacific and Latin America offer lucrative opportunities for stakeholders to tap into new geographic territories and offset restraint impact.

Key Features of the Study

This report provides in-depth analysis of the global biologics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global biologics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., AbbVie Inc., Amgen Inc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Gilead Sciences, Inc., Novartis AG, Bristol-Myers Squibb Company, Regeneron Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Eli Lilly and Company, and Celltrion Healthcare Co., Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global biologics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biologics market

Market Segmentation

By Product Insights (Revenue, USD Mn, 2019 - 2031)
- Monoclonal Antibodies
- Vaccines
- Recombinant Hormones/Proteins
- Cellular-based Biologics
- Gene-based Biologics
- Others
By Drug Classification Insights (Revenue, USD Mn, 2019 - 2031)
- Branded Drugs
- Generic Drugs
By Route of Administration Insights (Revenue, USD Mn, 2019 - 2031)
- Oral
- Parenteral
- Other Routes
By Mode of Purchase Insights (Revenue, USD Mn, 2019 - 2031)
- Prescription-Based Drugs
- Over-The-Counter Drugs
By Distribution Channel Insights (Revenue, USD Mn, 2019 - 2031)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Mn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- F. Hoffmann-La Roche Ltd.
- AbbVie Inc.
- Amgen Inc.
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi S.A.
- Gilead Sciences, Inc.
- Novartis AG
- Bristol-Myers Squibb Company
- Regeneron Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- Biogen Inc.
- Eli Lilly and Company
- Celltrion Healthcare Co., Ltd.

Product Code: CMI2663

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Biologics Market, By Product
- Global Biologics Market, By Drug Classification
- Global Biologics Market, By Route of Administration
- Global Biologics Market, By Mode of Purchase
- Global Biologics Market, By Distribution Channel
- Global Biologics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Biologics Market, By Product, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Recombinant Hormones/Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Cellular-based Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Gene-based Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

5. Global Biologics Market, By Drug Classification, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Branded Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Generic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Biologics Market, By Route of Administration, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Other Routes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Biologics Market, By Mode of Purchase, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Prescription-Based Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Over-The-Counter Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Biologics Market, By Distribution Channel, 2019-2031, (USD Mn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

9. Global Biologics Market, By Region, 2019 - 2031, (USD Mn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
Pfizer Inc.
Sanofi S.A.
Gilead Sciences, Inc.
Novartis AG
Bristol-Myers Squibb Company
Regeneron Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited
Biogen Inc.
Eli Lilly and Company
Celltrion Healthcare Co., Ltd.

11. References and Research Methodology

References
Research Methodology
About us